Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation

[21] Bhurtel S(2012)Toxin models of mitochondrial dysfunction in Parkinson’s disease Antioxid Redox Signal 16 920-48618

[22] Shadfar S(2010)Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide Pharmacol Rep 62 956-30

[23] Srivastav S(2000)Chronic systemic pesticide exposure reproduces features of Parkinson’s disease Nat Neurosci 3 1301-21

[24] Neupane S(2018)Metformin-induced mitochondrial complex i inhibition: facts, uncertainties, and consequences Front Endocrinol (Lausanne) 9 753-46

[25] Ojha U(2017)Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation Sci Rep 7 45465-21

[26] Lu M(2018)The therapeutic potential of metformin in neurodegenerative diseases Front Endocrinol (Lausanne) 9 400-undefined

[27] Su C(2017)Activation of the ATF2/CREB-PGC-1alpha pathway by metformin leads to dopaminergic neuroprotection Oncotarget 8 48603-undefined

[28] Qiao C(2017)Metformin impairs spatial memory and visual acuity in old male mice Aging Dis 8 17-undefined

[29] Bian Y(2018)Divergent effects of metformin on an inflammatory model of Parkinson’s disease Front Cell Neurosci 12 440-undefined

[30] Ding J(2014)Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice PLoS One 9 e91641-undefined

[21] Bhurtel S(2012)Toxin models of mitochondrial dysfunction in Parkinson’s disease Antioxid Redox Signal 16 920-48618

[22] Shadfar S(2010)Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide Pharmacol Rep 62 956-30

[23] Srivastav S(2000)Chronic systemic pesticide exposure reproduces features of Parkinson’s disease Nat Neurosci 3 1301-21

[24] Neupane S(2018)Metformin-induced mitochondrial complex i inhibition: facts, uncertainties, and consequences Front Endocrinol (Lausanne) 9 753-46

[25] Ojha U(2017)Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation Sci Rep 7 45465-21

[26] Lu M(2018)The therapeutic potential of metformin in neurodegenerative diseases Front Endocrinol (Lausanne) 9 400-undefined

[27] Su C(2017)Activation of the ATF2/CREB-PGC-1alpha pathway by metformin leads to dopaminergic neuroprotection Oncotarget 8 48603-undefined

[28] Qiao C(2017)Metformin impairs spatial memory and visual acuity in old male mice Aging Dis 8 17-undefined

[29] Bian Y(2018)Divergent effects of metformin on an inflammatory model of Parkinson’s disease Front Cell Neurosci 12 440-undefined

[30] Ding J(2014)Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice PLoS One 9 e91641-undefined